Related Experiment Videos
Current issues in burn wound infections
1University of California, California College of Medicine, Irvine.
Insights
Diagnosing burn wound infections in children requires high suspicion and daily evaluation. Early treatment focuses on gram-positive organisms, with later infections raising concern for nosocomial pathogens like P. aeruginosa.
Area of Science:
- Pediatric Infectious Diseases
- Burn Care and Management
- Wound Infection Microbiology
Background:
- Burn wound infection diagnosis in high-risk children is challenging, necessitating a high index of suspicion and consistent clinical evaluation.
- Effective management requires meticulous hygiene, prophylactic topical antibacterials (e.g., silver sulfadiazine cream), and routine surgical débridement.
Purpose of the Study:
- To outline diagnostic and therapeutic strategies for burn wound infections in pediatric patients.
- To emphasize the importance of timely and appropriate antimicrobial selection based on microbial surveillance and clinical presentation.
Main Methods:
- Routine weekly surveillance wound cultures to monitor colonization and guide antimicrobial therapy.
- Wound biopsy for histological examination and quantitative culture in severely ill children with unclear infections.
- Empirical systemic antibiotic therapy initiated for sepsis, guided by suspected pathogens based on the timing of infection.
Main Results:
- Early burn sepsis therapy should target gram-positive organisms; later infections suggest nosocomial pathogens (e.g., P. aeruginosa, enteric bacilli, C. albicans).
- Initial empirical regimens may include nafcillin plus ceftazidime or an aminoglycoside, with adjustments based on culture results.
- Antifungal (Amphotericin B) and antiviral (acyclovir) use should be reserved for confirmed disseminated infections.
Conclusions:
- Accurate diagnosis and prompt management, including surgical débridement and targeted antimicrobial therapy, are crucial for improving outcomes in pediatric burn wound infections.
- Further research into immunotherapy and immunomodulation may offer future strategies for preventing and treating severe burn-related infections.
- Understanding the evolving microbial landscape of burn wounds is essential for optimizing treatment regimens and reducing sepsis risk.
Abstract:
As we have emphasized, the diagnosis of burn wound infections in the high-risk burned child can be difficult and depends on a very high degree of suspicion and daily clinical evaluation of the burn wound site by consistent observers. Appropriate precautions include meticulous hand-washing and the use of gloves when handling the wound site and prophylactic application of a topical antibacterial agent such as SSD cream. Wound therapy should include routine vigorous surgical débridement. Surveillance wound cultures should be done weekly to determine the emergency of colonization and aid in the selection of empiric antimicrobial regimens when these are appropriate. Wound biopsy for histological examination and quantitative culture is highly recommended in the severely ill child with an unclear etiology or site of infection. If, despite these measures, sepsis ensues, then systemic antibiotics must be started empirically as an adjuctive therapy to surgical débridement. Knowledge of the organisms colonizing a wound will prove useful in choosing an antibiotic regimen while awaiting definitive results of blood and wound biopsy cultures. Without this information, early burn sepsis therapy should focus on gram-positive organisms, while infection later in the course should raise suspicion of nosocomial pathogens such as P. aeruginosa, other enteric bacilli, and C. albicans. An initial regimen might include nafcillin plus ceftazidime or an aminoglycoside, with anaerobic coverage depending on considerations noted previously. Once the causative agent is identified, therapy must be modified accordingly. Amphotericin B and acyclovir use should be guided by positive cultures from the burn wound site along with systemic evidence of dissemination. Available studies do not yet make clear the role of empiric immunotherapy with intravenous gamma globulin in the burned child. Therefore, its use cannot be recommended at the present time, although the development of specific immunoglobulins (P. aeruginosa, S. aureus) may prove useful in the future. In view of the multiplicity of organisms that may colonize burn wounds, it is likely that passive immunization may be more useful in the treatment of infection than in its prevention. The switch from P. aeruginosa to, for example, Klebsiella pneumoniae or E. cloacae, is not apt to be particularly beneficial in most circumstances. Similarly, an increased understanding of the role of the immune system in the propensity to burn sepsis may guide the development of vaccines or immunomodulators that decrease the risk of infection in seriously burned children and adults.